Roos I, Sharmin S, Malpas C, Ozakbas S, et al. Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Mult Scler 2024 Aug 1:13524585241267211. doi: 10.1177/13524585241267211.
PMID: 39087208